Advanced Filters
noise

High Blood Pressure (Hypertension) Clinical Trials

A listing of High Blood Pressure (Hypertension) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 94 clinical trials
F Florian Remund, MSc. Business Administration

Metreleptin in Anorexia Nervosa

The treatment of anorexia nervosa often proves to be difficult. There are no drugs that work specifically for the treatment of anorexia nervosa. Experimental administration of metreleptin (synthetically produced leptin) to patients with anorexia nervosa has produced positive results. This study tests the effect of metreleptin in comparison with placebo, …

17 - 65 years of age Both Phase 2
C Colleen McCallum, MBA

Gastrointestinal Interoception in Anorexia Nervosa

Anorexia nervosa (AN) has among the highest mortality rate of any psychiatric illness, yet we have a poor understanding of the biological causes of this disorder. In this study, we use a novel mechanosensory intervention to examine the basic question of whether individuals with AN have abnormal "gut sensations" and …

15 - 40 years of age Female Phase N/A
S Sanna A Gustafsson, Ass Prof

Treatment of Adolescent Anorexia Nervosa

VISAN is a naturalistic study of family based treatment of Anorexia nervosa in adolescnet girls.

11 - 17 years of age Both Phase N/A

Trial of Enhanced Neurostimulation for Anorexia

Preliminary open-label studies have suggested that non-invasive brain stimulation methods of both transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS) have clinical benefits for improving psychological and eating disorder related symptoms, which can persist at long-term follow ups after acute treatment (i.e., at 6 and 12 months). …

16 - 100 years of age Both Phase N/A
C Cheri A Levinson, Ph.D.

Facing Eating Disorder Fears for Anorexia Nervosa

FED-F is a modular treatment that enhances exposure therapy with psychoeducation and cognitive skills teaching how to face fears of (a) food, (b) weight gain, (c) interoception/body, and (d) social situations. The study goals are to (1) refine and test the acceptability and feasibility of FED-F treatment (Phase I), (2) …

18 - 65 years of age Both Phase N/A
P Pouneh K Fazeli, MD

Transdermal Estrogen in Women With Anorexia Nervosa

Randomized, placebo-controlled study investigating the use of physiologic, transdermal estrogen for low bone mass in adult women with anorexia nervosa.

19 - 45 years of age Female Phase 2
V Viviane AWASSI

Deep Brain Stimulation for Severe Anorexia Nervosa

The somatic complications as well as the suicidal risk make Anorexia Nervosa (AN) the psychiatric disease with the highest mortality rate: the standardized mortality ratio is higher than 4 and 1 in 5 patients with AN who dies has committed suicide. Approximately 20% of patients suffering from AN evolves into …

18 - 65 years of age Both Phase N/A
T Tristan GABRIEL-SEGARD, Md

Food Intake and IgA Microbiota in Anorexia Nervosa

Anorexia nervosa is characterized by intestinal dysbiosis, related to the feeding behavior impairment presented by these patients. Pathophysiologic hypotheses are involving the trouble of the microbiota-gut-brain axis in the field of mental diseases.

18 - 50 years of age Female Phase N/A
T Tom Hildebrandt

Metabolic Diet for Relapse Prevention in Anorexia Nervosa

This is an interventional study that will test the safety, tolerability, and efficacy of the Metabolic Diet, which was designed as a treatment for women with anorexia nervosa to remain weight-stable after they have been restored from low weight. Participants will be adult women with anorexia nervosa who have been …

18 - 40 years of age Female Phase N/A
L Lisa Fredenburg, MS

Study of Psilocybin for Anorexia in Young Adults

This is a single site trial of psilocybin therapy for the treatment of refractory Anorexia Nervosa in young adults. The psilocybin therapy will include three preparatory sessions, psilocybin dosing session one (20mg), two integration sessions, psilocybin dosing session two (30mg), and four final integration sessions. Eating disorder symptoms will be …

18 - 25 years of age Both Phase 2

Rewrite in simple language using AI